Bentham Science Logo

Track Your Manuscript:

Current Cancer Drug Targets

Volume 22, 11 Issues, 2022
ISSN: 1873-5576 (Online)
ISSN: 1568-0096 (Print)
This journal supports open access


Current Cancer Drug Targets , Volume 8 - Number 8

mTOR Pathway and mTOR Inhibitors as Agents for Cancer Therapy

, 8(8): 647 - 665

Paolo Baldo, Sara Cecco, Elisa Giacomin, Renzo Lazzarini, Barbara Ros and Stefano Marastoni

DOI: 10.2174/156800908786733513

Melatonin as a Selective Estrogen Enzyme Modulator

, 8(8): 691 - 702

S. Cos, A. Gonzalez, C. Martinez-Campa, M. D. Mediavilla, C. Alonso-Gonzalez and E. J. Sanchez-Barcelo

DOI: 10.2174/156800908786733469

Choline Kinase Alpha Depletion Selectively Kills Tumoral Cells

, 8(8): 709 - 719

Monica Banez-Coronel, Ana Ramirez de Molina, Agustin Rodriguez-Gonzalez, Jacinto Sarmentero, Mª Angeles Ramos, Miguel Angel Garcia-Cabezas, Lourdes Garcia-Oroz and Juan Carlos Lacal

DOI: 10.2174/156800908786733432

Protective Effect of NSAIDs on Cancer and Influence of COX-2 C G Genotype

, 8(8): 753 - 764

C. Siemes, L. E. Visser, J. W.W. Coebergh, A. Hofman, A. G. Uitterlinden and B.H. Ch. Stricker

DOI: 10.2174/156800908786733414


Ruiwen Zhang
Center for Drug Discovery
University of Houston
Houston, TX
View Full Editorial Board

COPE Compliant

Cope Logo

Journal History

Current Cancer Drug Targets was launched in 2001. Dr. Ruiwen Zhang serves as the Editor-in-Chief of the journal.



Related Journals

Related eBooks

eBooks Catalog